Genome CNVs from leukocytes predicting short PSADT correlated with lower PSA-free survival.

Abstract

<p>Kaplan-Meier analysis on patients predicted by LSR based on CNV of patients’ leukocytes as likely recurrent and having PSADT 4 months or less versus likely non-recurrent or recurrent but having PSADT 15 months or more (upper left). Similar survival analyses were also performed on case segregations based on Gleason’s grades (upper middle), Nomogram probability (upper right), the status of 8 fusion transcripts (lower left), or a model by combining LSR, Nomogram and fusion transcript status using LDA (lower middle), or a model by combining LSR, Nomogram, Gleason grade and fusion transcript status using LDA (lower right). Number of samples analyzed and p values are indicated.</p